Table 2 Pre-specified comorbidities and disease-associated symptoms of patients with prevalent HD in 2015 and 2016
Women (n = 139) | Men (n = 169) | All (n = 308) | ||||
|---|---|---|---|---|---|---|
n | % | n | % | n | % | |
ADHD | 8 | 5.8% | 8 | 4.7% | 16 | 5.2% |
Anxiety | 26 | 18.7% | 12 | 7.1% | 38 | 12.3% |
Bipolar disorder | < 5 | / | / | / | < 5 | / |
Depression | 64 | 46.0% | 68 | 40.2% | 132 | 42.9% |
Diabetes mellitus | 16 | 11.5% | 18 | 10.7% | 34 | 11.0% |
Dysphagia | 35 | 25.2% | 53 | 31.4% | 88 | 28.6% |
Extrapyramidal and movement disorders | 42 | 30.2% | 52 | 30.8% | 94 | 30.5% |
Insomnia | 20 | 14.4% | 21 | 12.4% | 41 | 13.3% |
Obsessive compulsive disorder | < 5 | / | / | / | < 5 | / |
Osteoarthritis | 31 | 22.3% | 24 | 14.2% | 55 | 17.9% |
Other systemic atrophies (excl. HD) | < 5 | / | / | / | 8 | 2.6% |